6|0|Public
5000|$|<b>Hydroxypethidine</b> (ethyl 4-(m-hydroxyphenyl)-1-methylpiperidine-4-carboxylate) ...|$|E
50|$|<b>Hydroxypethidine</b> (Bemidone) is an opioid {{analgesic}} {{that is an}} analogue of pethidine (meperidine). <b>Hydroxypethidine</b> is significantly less potent than meperidine as an analgesic, (0.3x meperidine in potency) although it also has NMDA antagonist properties like its close relative ketobemidone.|$|E
50|$|<b>Hydroxypethidine</b> {{has similar}} effects to other opioids, and {{produces}} analgesia, sedation and euphoria. Side effects can include itching, nausea and potentially serious respiratory depression {{which can be}} life-threatening.|$|E
50|$|Methylketobemidone is {{so named}} {{because it is the}} methyl ketone {{analogue}} of bemidone (<b>hydroxypethidine).</b> The more commonly used ethyl ketone ("ethylketobemidone") is simply called ketobemidone, as it is the only drug of this family to have been marketed.|$|E
5000|$|<b>Hydroxypethidine</b> {{is under}} {{international}} control under the Single Convention on Narcotic Drugs 1961 and therefore controlled like morphine in most countries; in the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9627 and a 2014 annual aggregate manufacturing quota of 2 grammes. The salt in use is the hydrochloride, {{with a free}} base conversion ratio of 0.878.|$|E

